Concepedia

Publication | Open Access

Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial

DOIFull Paper Access

237

Citations

11

References

2022

Year

José Manuel Pérez-García, Marta Vaz Batista, Patricia Cortez, Manuel Ruíz‐Borrego, Juan Miguel Cejalvo, Juan de la Haba-Rodríguez, Laia Garrigós, Fabricio Racca, Sonia Servitja, Salvador Blanch,
Neuro-Oncology

Abstract

T-DXd showed intracranial activity with manageable toxicity and maintained the quality of life in pretreated HER2-positive ABC patients with stable, untreated, or progressing BMs. Further studies are needed to validate these results in larger cohorts.

References

YearCitations

Page 1